Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Atrimed Pharmaceuticals
Location
People
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
Network
T. Score
Registered Details

Get this company's details upto March 2024. FREE access. Sign up now!

ATRIMED PHARMACEUTICALS PRIVATE LIMITED

All Companies ›

Karnataka ›

Agriculture ›

Active

Updated: 11 Apr 2025

Atrimed Pharmaceuticals Private Limited, is an unlisted private company incorporated on 03 July, 2003. It is classified as a private limited company and is located in Bangalore, Karnataka. It's authorized share capital is INR 8.50 cr and the total paid-up capital is INR 8.16 cr.

Atrimed Pharmaceuticals's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2022. It's EBITDA has decreased by 68.69% over the previous year. At the same time, it's book networth has increased by 16.74%.

Subscription Plans

Industry and products

Agriculture and Allied Activities

Hospital activities

Company size

Auth Capital

₹ 8.5 Cr

Paidup Capital

₹ 8.2 Cr

Revenue

₹ 10-25 cr

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue

-5.39%

₹ GET PRO

EBITDA

10.85%

₹ GET PRO

Net Profit

-82.88%

₹ GET PRO

Networth

1.52%

₹ GET PRO

Borrowings

-6.01%

₹ GET PRO

Assets

5.49%

₹ GET PRO

Gross Margin

-3.19

GET PRO %

Operating Margin

0.24

GET PRO %

Net Profit Margin

-1.43

GET PRO %

Return on Equity

-7.39

GET PRO %

ROCE

0.05

GET PRO %

Debt to Equity

-0.04

GET PRO

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

Buy credits

View subscriptions

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (11)

State	Type	Address

Locations on Map

People

Designation	Name	DIN/PAN	Tenure
Director	Hrishikesh Damle Shareholder	00574119	22 years
Director	Shibban Krishen Ganju Shareholder	01966923	15 years
Director	Latha Damle Shareholder	07038353	4 years
Director	Rishi Ganju Shareholder	09313050	4 years

Financial Highlights

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	8.2	8.2	8.2	8.2
Reserves	-4.5	-3.9	-3.5	-3.5
Borrowings +	1.7	1.4	2.7	2.6
Long term borrowings	1.2	1.4	1.6	1.5
Short term borrowings	0.4	-	1.1	1.1
Trade payables +	3.2	2.8	2.4	3.9
Days payable	105.0	122.0	114.0	193.0
Other liabilities +	7.2	6.8	6.1	6.9
Other non-current liabilities	0.6	0.6	0.7	0.7
Other current liabilities	3.4	3.4	2.9	2.2
Total liabilities	12.6	12.6	13.5	14.1
Fixed Assets +	1.7	1.5	1.7	1.5
Tangible assets	1.6	1.5	1.7	1.5
CWIP	-	-	-	-
Intangible assets	-	-	-	-
LT loans and advances	-	-	-	-
Other non-current assets	0.1	0.2	0.3	0.3
Current assets +	10.8	10.9	11.4	12.3
Inventories	2.5	2.9	3.6	4.5
Trade receivables	2.0	1.2	1.7	1.4
Cash and cash equivalents	3.6	3.5	3.9	4.1
ST loans and advances	2.7	3.3	2.3	2.3
Other current assets	-	-	-	-
Total assets	12.6	12.6	13.5	14.1

Percentage of assets	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	64.96	64.95	60.55	57.84
Reserves	-35.79	-30.67	-26.0	-24.64
Borrowings +	13.36	11.48	20.2	18.14
Long term borrowings	9.88	10.84	11.79	10.49
Short term borrowings	3.48	0.64	8.41	7.65
Trade payables	25.78	22.37	17.81	27.73
Other liabilities +	57.46	54.25	45.25	48.66
Other non-current liabilities	4.44	4.95	5.54	5.2
Other current liabilities	27.25	26.93	21.9	15.73
Total liabilities
Fixed Assets +	13.16	11.9	12.62	10.59
Tangible assets	12.85	11.71	12.55	10.56
CWIP	0.0	0.0	0.0	0.0
Intangible assets	0.3	0.18	0.07	0.03
LT loans and advances	0.0	0.0	0.0	0.0
Other non-current assets	0.88	1.4	2.38	2.4
Current assets +	85.97	86.7	85.0	87.01
Inventories	19.78	22.88	26.39	31.7
Trade receivables	15.93	9.76	12.61	10.27
Cash and cash equivalents	28.4	27.87	28.83	28.92
ST loans and advances	21.85	26.18	17.17	16.12
Other current assets	0.0	0.0	0.0	0.0
Total assets

Total assets

Charges on assets

Bank wise

Charges

HDFC Bank Limited

No. of Loans: 1

Total Amount : 0.4 cr

Charge Holder	Amount	Date of creation/modification
HDFC Bank Limited	0.4 cr	31 Oct, 2022

Charges

HDFC Bank Limited

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
ATRIMED HEALTH CONSULTANTS PRIVATE LIMITED	Strike Off	1.0 L	1	Karnataka
ATRIMED HEALTH CARE FOUNDATION	Active	0.0	1	Karnataka
GOLF-ALL-SEASON HOLIDAYS PRIVATE LIMITED	Strike Off	1.0 L	2	Karnataka
MAHILA HEALTHCARE PRIVATE LIMITED	Active	1.0 L	2	Karnataka
SAVE A MOTHER FOUNDATION	Active	0.0	2	Karnataka
ATRIMED PLANT SCIENCE PRIVATE LIMITED	Active	1.0 L	2	Karnataka
DAMLE & GANJU HEALTH CONSULTANTS LLP	Active	50,000.0	2	Karnataka
CHICAGO INDIA HEALTH INFRASTRUCTURE PRIVATE LIMITED	Strike Off	1.0 L	1	Karnataka
ATRIMED BIO-TECH LLP	Active	1.0 L	1	Karnataka

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
MAHILA HEALTHCARE PRIVATE LIMITED	Karnataka	2020	₹ 1.0 L

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

CIN

U02423KA2003PTC032200

PAN

AAECA2885Q

Incorporation

2003, 22.0 years

Company Email

info@atrimed.com

Paid up Capital

₹ 8.2 Cr

Authorised Capital

₹ 8.5 Cr

AGM

Sep 2023

Type

Private

Non-government Company

FAQ - ATRIMED PHARMACEUTICALS PRIVATE LIMITED

What is the incorporation date of ATRIMED PHARMACEUTICALS PRIVATE LIMITED?

The incorporation date of ATRIMED PHARMACEUTICALS PRIVATE LIMITED is 03 July, 2003

What is the authorized share capital of ATRIMED PHARMACEUTICALS PRIVATE LIMITED?

The authorized share capital of ATRIMED PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 8.5 Cr.

What is the paid-up capital of ATRIMED PHARMACEUTICALS PRIVATE LIMITED?

The paid-up capital of ATRIMED PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 8.2 Cr.

What is the registered address of ATRIMED PHARMACEUTICALS PRIVATE LIMITED?

The registered address of ATRIMED PHARMACEUTICALS PRIVATE LIMITED is No.755, 3rd Cross,11th Block, 2nd Stage, BDA Layout, Nagar bhavi Bangalore NA Bangalore Bangalore Karnataka - 560072

What is the CIN number of ATRIMED PHARMACEUTICALS PRIVATE LIMITED?

The CIN number of ATRIMED PHARMACEUTICALS PRIVATE LIMITED is U02423KA2003PTC032200.

Smart Suggestions

Top Blog Post

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

ATRIMED PHARMACEUTICALS PRIVATE LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Buy Report or Plans

Dashboards

Company dashboard

Buy credits

View subscriptions

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Choose number of credits to buy

₹ 449 + GST

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

People

Financial Highlights

Margins

Balance Sheet

Total assets

Charges on assets

Charges

Company Network